Archives: Agenda

Unlocking the potential of Latin America: Opportunities, partnerships and strategic growth

  • Evolving Regulatory Environment: Significant regulatory reforms across Latin American countries aiming to align with international standards (e.g., ICH guidelines)
  • Opportunities Arising from Regulatory Changes: Faster approval timelines enabling quicker trial initiation
  • Role of Vendors in Fostering Opportunities: Need for vendors to adapt to local regulatory nuances and evolving compliance requirements
  • Turning to Latin America for a genetically diverse population, valuable for global clinical research, but also understanding the need for culturally sensitive patient engagement strategies to improve recruitment and retention

Placing fear reduction at the core of the patient experience strategy: Assessing the impact of diminished anxiety and increased sense of control for oncology clinical trials

  • Improving the sense of security to reduce unnecessary suffering and distress for patients
  • Understanding the different types of patients and their individual response behaviours
  • Being hyper aware of cultural differences and biases to ensure sensitivity and effective outcomes for all
  • Sharing best practice on effective strategies with case studies and examples to help reduce patient drop out rate

From barriers to progress: Advancing oncology trial success through a patient-first approach in eClinical technology

  • Focus on the challenges patients face in trials: Learn what the data reveals about barriers to oncology trial participation and the toll of patient dropout.
  • Learn how technology (when done right) can make trials easier for oncology patients: Explore solutions like travel support, streamlined patient payments, and eCOA.
  • Hear success stories: Find out how recent case studies of eClinical solutions improved the patient and site experience.
  • See how a Platform approach creates a smoother experience for patients and sites: Get the latest on the Suvoda-Greenphire merger and its suite of eight unified solutions.